Skip to main content
Contact Us
Subscribe
E-Edition
85°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about 5/MeO/DMT
Recent news which mentions 5/MeO/DMT
Mike Tyson On Psychedelics: 'The Toad Showed Me God, And It Changed My Life'
November 14, 2024
Tickers
NEWS
Tags
Jake Paul
News
5/MeO/DMT
From
Benzinga
Imperial College Scientists Dose First Patient With 5-MeO-DMT To Examine One Of The Most Potent Psychedelics' Effects On The Brain
June 03, 2024
Tickers
NEWS
Tags
Psychedelics
psychedelics study
Benzinga
From
Benzinga
First Patient Dosed In Psychedelics Therapy Study For Treatment-Resistant Depression
April 26, 2024
Tickers
NEWS
Tags
Market News
Cannabis
BPL/003
From
Benzinga
Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression
March 28, 2024
Tickers
ATAI
NEWS
Tags
News
treatment/resistant depression
5/MeO/DMT
From
Benzinga
GH Research: This European Biotech Company Reports Full Year 2023 Financial Results And Business Updates
February 29, 2024
Tickers
GHRS
NEWS
Tags
Psychedelics
Benzinga
Biotech
From
Benzinga
Atai Invests $50M In Beckley Psytech For Short-Duration Psychedelics Development
January 04, 2024
Tickers
ATAI
GHRS
NEWS
Tags
Psychedelics
News
Penny Stocks
From
Benzinga
GH Research: Steady Expenses And $229M Cash Position For 2026 Runway
November 14, 2023
Tickers
GHRS
Tags
News
5/MeO/DMT
Markets
From
Benzinga
GH Research's Psychedelic Drug Candidate For Depression Meets FDA: Clinical Program On Hold
October 02, 2023
Tickers
GHRS
Tags
Benzinga
5/MeO/DMT
News
From
Benzinga
GH Research Psychedelics Firm Q2 2023 Reports $238M Cash To Accelerate 5-MeO-DMT Programs Into 2026
August 24, 2023
Tickers
GHRS
Tags
Benzinga
Psychedelics
GHRS
From
Benzinga
Harnessing The Power Of 5-MeO-DMT For Women Trauma Survivors: A Specialized Retreat
July 03, 2023
Tags
5/MeO/DMT
Management
Benzinga
From
Benzinga
All On Board For 5-MeO-DMT: This Retreat Hosts Expertly Guided Experiences For Women, BIPOC
July 02, 2023
Tags
Psychedelics
Benzinga
Interview
From
Benzinga
GH Research: Q1 2023 Financials And Businesses For European 5-MeO-DMT Depression Treatment Developer
May 11, 2023
Tickers
GHRS
Tags
GHRS
Biotech
Earnings
From
Benzinga
Beckley Psytech Begins Phase IIa Study Of Psychedelic Compound To Treat Depression
May 04, 2023
Tags
Biotech
Benzinga
Psychedelics
From
Benzinga
UK-Based Approach To Alcohol Addiction: 5-MeO-DMT Candidate Moves To Phase 2 Clinical Stage
April 05, 2023
Tags
alcohol use disorder
5/MeO/DMT
Benzinga
From
Benzinga
2 Psychedelics Companies Tout Advanced Clinical Trials, Progress With Key Products
January 11, 2023
Tickers
GHRS
PHRRF
Tags
GHRS
FDA
Benzinga
From
Benzinga
New Sublingual Psychedelic Drug Candidate Created For Depression And Anxiety In Alzheimer's
December 29, 2022
Tickers
BMNDF
Tags
Next/Generation Psychedelics
Drug Delivery Technologies
Market News
From
Benzinga
Phase 2 Trial For This Psychedelic, Potential Treatment For Severe Depression
December 22, 2022
Tags
Market News
Cannabis
Markets
From
Benzinga
Psychedelic Experiences: UCL Leads First-Ever Brain Imaging Study In Retreat Participants
December 07, 2022
Tags
Psychedelics
Benzinga
University College London
From
Benzinga
Beyond Magic Mushrooms: Positive Clinical Trial For Treatment-Resistant Depression & Alcoholism
November 16, 2022
Tags
5/MeO/DMT
Beckley Psytech
Benzinga
From
Benzinga
Psychedelics Company's $60M Series A For Startup To Develop Treatment For Mental Health Disorders
November 02, 2022
Tags
News
Catalent
Lusaris Therapeutics
From
Benzinga
Can Psychedelics Alleviate Prolonged Grief? Austin's Dell Med School Launches Clinical Trial To Find Out
October 18, 2022
Tags
5/MeO/DMT
Benzinga
Psychedelics
From
Benzinga
Canadian Psychedelics Firm And Queens College Develop New Transdermal Drug Delivery System
September 27, 2022
Tickers
BMNDF
Tags
Benzinga
BMNDF
5/MeO/DMT
From
Benzinga
Clinical Study On DMT Inhaled Product For Treatment-Resistant Depression Completes Dosing Stage
September 23, 2022
Tickers
BMNDF
Tags
DMT Clinical Trial
Markets
Cannabis
From
Benzinga
DMT Producer PsyBio And Shrooms Grower Red Light Holland Share Their Most Recent Financial Results
August 29, 2022
Tickers
DMT
PSYBF
TRUFF
Tags
PSYBF
Retail Sales
TRUFF
From
Benzinga
GH Research Shares Q2 2022 Financial Results & Business Updates
August 23, 2022
Tickers
GHRS
Tags
Market News
Earnings
Markets
From
Benzinga
Inside A 5-MeO-DMT Retreat: Who Should And Shouldn't Embark On This 'Hero's Journey'
February 12, 2022
Tickers
DMT
Tags
contributors
DMT
Benzinga
From
Benzinga
5 Psychedelics For Mental Health
February 01, 2022
Tags
mental health
psychedelics
contributors
From
Benzinga
Beckley Psytech Begins Training Therapists For Phase 2 Trial With Toad Venom, 5-MeO-DMT
January 24, 2022
Tags
News
General
Benzinga
From
Benzinga
A Deeper Look At DMT, The 'Spirit Molecule'
January 12, 2022
Tickers
DMT
Tags
Cannabis
Markets
Market News
From
Benzinga
GH Research Announces Positive Trial Results For Treatment-Resistant Depression
December 06, 2021
Tickers
GHRS
Tags
5/MeO/DMT
MIke Tyson
News
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.